Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Biopharmx	Anatara Lifesciences	Skinbiotherapeutics	Briacell Therapeutics	Hemostemix
Symbol	NYSEAMERICAN:BPMX	ASX:ANR	LON:SBTX	CVE:BCT	CVE:HEM
Price Information
Current Price	$2.66	A$0.20	GBX 14.13	C$9.99	C$0.01
52 Week Range	Hold	N/A	N/A	N/A	N/A
Beat the Market™ Rank
Overall Score	1.2	0.5	0.4	0.5	0.7
Analysis Score	3.0	0.0	0.0	0.0	0.0
Community Score	3.1	2.4	2.2	2.7	2.7
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	0.0	0.0
Earnings & Valuation Score	0.0	0.0	0.0	0.0	0.6
Analyst Ratings
Consensus Recommendation	Hold	N/A	N/A	N/A	N/A
Consensus Price Target	$12.00	N/A	N/A	N/A	N/A
% Upside from Price Target	351.13% upside	N/A	N/A	N/A	N/A
Trade Information
Market Cap	$75.12 million	$9.97 million	£18.09 million	C$6.49 million	C$9.07 million
Beta	N/A	N/A	N/A	N/A	N/A
Average Volume	2,150,348	N/A	261,826	951	795,314
Sales & Book Value
Annual Revenue	N/A	$594,136.00	N/A	N/A	N/A
Price / Sales	N/A	16.78	N/A	N/A	N/A
Cashflow	N/A	A$0.09 per share	GBX 1.60 per share	C$0.12 per share	C$0.00 per share
Price / Cash	N/A	2.33	8.82	79.92	10.00
Book Value	N/A	A$0.09 per share	GBX 2.40 per share	C($4.14) per share	C($0.01) per share
Price / Book	N/A	2.33	N/A	N/A	N/A
Profitability
Net Income	N/A	N/A	N/A	N/A	N/A
EPS	N/A	A($0.05)	GBX (1.10)	C($10.14)	C($0.02)
Trailing P/E Ratio	0.00	N/A	N/A	N/A	N/A
Forward P/E Ratio	∞	∞	∞	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	N/A	N/A	N/A	N/A	N/A
Return on Assets (ROA)	N/A	N/A	N/A	N/A	N/A
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	48.40%	N/A
Current Ratio	N/A	9.62%	15.76%	0.08%	0.09%
Quick Ratio	N/A	9.47%	15.76%	0.03%	0.09%
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	17	N/A	6	N/A	N/A
Shares Outstanding	18.28 million	49.86 million	128.08 million	722,000	730.16 million
Next Earnings Date	6/9/2020 (Estimated)	N/A	N/A	6/25/2020 (Estimated)	N/A
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources